A device to improve safety and efficiency in hemodialysis treatments
Self-sealing needle guide system for reliable hemodialysis
This study is testing a new implantable device that helps make it easier and safer for patients on hemodialysis to get their needles in the right spot, which could lower the chances of infections and other problems during treatment.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Flowpoint Medical INC NIH-funded |
| Lab location | 1 site (Overland Park, United States) |
| Project ID | NIH-11237368 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative implantable device designed to enhance vascular access for patients undergoing hemodialysis. The device features a 3D-printed titanium shell that accurately guides the hemodialysis needle to the correct insertion point, while a specialized valve minimizes bleeding upon needle removal. By improving the safety and reliability of needle placement, this device aims to reduce the risks of infection and complications during hemodialysis treatments. The research will involve refining the device's design and conducting preclinical studies to evaluate its effectiveness in large animal models.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with end-stage kidney disease who require regular hemodialysis treatments.
Not a fit: Patients who are not undergoing hemodialysis or those with conditions that do not require vascular access for dialysis will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the safety and efficiency of hemodialysis treatments for patients with end-stage kidney disease.
How similar studies have performed: While this approach is innovative, similar research in improving vascular access for dialysis has shown promise, indicating potential for success.
Where this research is happening
Overland Park, United States
- Flowpoint Medical INC — Overland Park, United States (Active)
Researchers
- Principal investigator: Bobe, Jason — Flowpoint Medical INC
- Study coordinator: Bobe, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.